Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
Abroad (travel likely)RecruitingPHASE2
Conditions
Triple Negative Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Study leads
Wenjin Yin, M.D.
Principal Investigator
Renji Hospital,School of Medicine, Shanghai Jiaotong University